Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

392.64
Delayed Data
As of May 23
 +6.64 / +1.72%
Today’s Change
348.96
Today|||52-Week Range
605.93
-27.67%
Year-to-Date
Baron Funds Comments on Regeneron Pharmaceuticals
May 23 / GuruFocus News - Paid Partner Content
3 Stocks You Can Buy and Hold Forever
May 16 / MotleyFool.com - Paid Partner Content
History Says Now Is The Time To Buy This Biotech Firm
May 18 / StreetAuthority - Paid Partner Content
Biotech groups sink their teeth into the Big Apple
May 16 / FT.com - Paid Partner Content
Regeneron Pharmaceuticals (REGN) Stock is the 'Chart of the Day'
May 18 / TheStreet.com - Paid Partner Content
5 Growth Stocks to Buy in May
May 14 / MotleyFool.com - Paid Partner Content
Regeneron May Cure the Market Blues
May 18 / TheStreet.com - Paid Partner Content
Stock Market News for May 13, 2016
May 13 / Zacks.com - Paid Partner Content
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Ophthotech
May 17 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close386.00
Today’s open386.46
Day’s range384.31 - 396.99
Volume1,086,269
Average volume (3 months)1,008,121
Market cap$40.6B
Dividend yield--
Data as of 05/23/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-6.20%
Earnings growth (next 5 years)+17.70%
Revenue growth (last year)+45.55%
P/E ratio62.3
Price/Sales15.24
Price/Book11.05

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.58-0.87%
ALNYAlnylam Pharmaceutic...+0.96+1.74%
IONSIonis Pharmaceutical...+0.49+1.46%
CRLCharles River Labora...-0.10-0.12%
Data as of 05/23/2016

Financials

Next reporting dateAugust 2, 2016
EPS forecast (this quarter)$2.69
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts

Partner Offers

Search for Jobs